The counts of WBC, Hb, and PLT in patients with cervical cancer before postoperative treatment were 7.18 ± 1.10 109/L, 120.55 ± 10.02, and 214.37 ± 10.14 109/L. This evidence concerns the gene GSTM1 and cervical carcinoma.